A Case Study IMA Active and Medochemie have joined forces in order to achieve optimal low-dose dry powder inhalers by combining the dosator technology and the di...

The largest threat currently faced by humankind is the ever-rising CO2 levels in the air we breathe. In our lifetime, the CO2 level has increased by 33% from 300ppm ...

The inhalation of dry powders is one of the oldest forms of delivering active substances via the pulmonary route. Despite the progress in DPI drug delivery technolog...

Individuals involved in drug development are faced with many different challenges along the process of seeking regulatory approval. Imaging plays an important role i...

An undertaking is defined as dominant if it enjoys such a significant market position as to grant it the power to behave, to an appreciable extent, independently of ...

IO has witnessed a long history of highs and lows. Although conventional cytokines and vaccine immunotherapies were approved for certain cancers, high toxicities, lo...

Climate change is perhaps the most complex issue facing modern society, affecting every aspect of human life. According to a Lancet report, spending on climate chang...

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterised with focal confluent lesions of primary demyelination fo...

It is no mystery to the pharmaceutical and biotech industry that between 2018 and 2023, several original reference biologics will be coming off patent. This clearly ...

Developing a medical device is no easy task and knowing where to start is the first hurdle. Spending time early on working out which is the right path will not only ...